[{"address1": "200 Minuteman Road", "address2": "Suite 302", "city": "Andover", "state": "MA", "zip": "01810", "country": "United States", "phone": "978 552 0900", "website": "https://www.transmedics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.", "fullTimeEmployees": 584, "companyOfficers": [{"maxAge": 1, "name": "Dr. Waleed H. Hassanein M.D.", "age": 55, "title": "Founder, President, CEO & Director", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 1817496, "exercisedValue": 13381959, "unexercisedValue": 45252580}, {"maxAge": 1, "name": "Mr. Nicholas  Corcoran", "age": 40, "title": "Senior Vice President of Supply Chain & Operations", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 812071, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anil  Ranganath", "title": "Senior VP, General Counsel & Corporate Secretary", "fiscalYear": 2023, "totalPay": 561674, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tamer I. Khayal M.D.", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 900108, "exercisedValue": 5450721, "unexercisedValue": 5052497}, {"maxAge": 1, "name": "Mr. Gerardo  Hernandez", "title": "Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Miriam C. Provost Ph.D.", "age": 62, "title": "Vice President of Global Regulatory Affairs", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 535930, "exercisedValue": 390248, "unexercisedValue": 1664774}], "auditRisk": 2, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 3, "overallRisk": 3, "governanceEpochDate": 1733011200, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 62.6, "open": 62.0, "dayLow": 59.965, "dayHigh": 62.3, "regularMarketPreviousClose": 62.6, "regularMarketOpen": 62.0, "regularMarketDayLow": 59.965, "regularMarketDayHigh": 62.3, "beta": 2.071, "trailingPE": 65.6129, "forwardPE": 43.259106, "volume": 1199016, "regularMarketVolume": 1199016, "averageVolume": 1825592, "averageVolume10days": 1242270, "averageDailyVolume10Day": 1242270, "bid": 60.89, "ask": 61.18, "bidSize": 700, "askSize": 500, "marketCap": 2047922688, "fiftyTwoWeekLow": 59.722, "fiftyTwoWeekHigh": 177.37, "priceToSalesTrailing12Months": 5.105893, "fiftyDayAverage": 83.7605, "twoHundredDayAverage": 120.34843, "currency": "USD", "enterpriseValue": 2258797568, "profitMargins": 0.08137, "floatShares": 32545274, "sharesOutstanding": 33561500, "sharesShort": 9291382, "sharesShortPriorMonth": 8426990, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.2768, "heldPercentInsiders": 0.03214, "heldPercentInstitutions": 1.12947, "shortRatio": 4.14, "shortPercentOfFloat": 0.3367, "impliedSharesOutstanding": 33561500, "bookValue": 6.255, "priceToBook": 9.755396, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": 32638000, "trailingEps": 0.93, "forwardEps": 1.65, "enterpriseToRevenue": 5.632, "enterpriseToEbitda": 44.171, "52WeekChange": -0.20546877, "SandP52WeekChange": 0.25891924, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "TMDX", "underlyingSymbol": "TMDX", "shortName": "TransMedics Group, Inc.", "longName": "TransMedics Group, Inc.", "firstTradeDateEpochUtc": 1556803800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "92140e2a-40a2-3a8f-af5f-f1195b90106c", "messageBoardId": "finmb_429233", "gmtOffSetMilliseconds": -18000000, "currentPrice": 61.02, "targetHighPrice": 125.0, "targetLowPrice": 75.0, "targetMeanPrice": 102.0, "targetMedianPrice": 104.0, "recommendationMean": 1.77778, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 330094016, "totalCashPerShare": 9.835, "ebitda": 51138000, "totalDebt": 518145984, "quickRatio": 6.998, "currentRatio": 8.201, "totalRevenue": 401089984, "debtToEquity": 246.83, "revenuePerShare": 12.157, "returnOnAssets": 0.02836, "returnOnEquity": 0.19405001, "freeCashflow": -142587504, "operatingCashflow": 37444000, "revenueGrowth": 0.637, "grossMargins": 0.59336, "ebitdaMargins": 0.1275, "operatingMargins": 0.03607, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-28"}]